Virtual reality meets AI: could a headset calm IBD anxiety?

NCT ID NCT07590518

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests whether an AI-enhanced virtual reality cognitive behavioral therapy (VR/AI CBT) program can reduce anxiety and improve quality of life in people with inflammatory bowel disease (IBD). Seventy-six adults with IBD and moderate-to-severe anxiety will be randomly assigned to either the VR/AI CBT program or a distraction VR program for 8 weeks. Researchers will measure changes in anxiety scores and how usable the VR system is.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
AI-enhanced virtual reality cognitive behavioral therapy (VR/AI CBT) program
What this could lead to
If it works, this could offer a new, drug-free way to manage anxiety and improve daily life for people with inflammatory bowel disease.
What could go wrong
This is a small, early pilot study with only 76 participants, so results may not apply to everyone. The VR program is only available in English, which limits who can join.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ANXIETY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Cedars-Sinai Medical Center

    Los Angeles, California, 90048, United States

  • University of Chicago

    Chicago, Illinois, 60637, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.